ライフサイエンスコーパス: patients

1 ransplant, or admission for heart failure was reached in 88 patients.

2 Causal copy-number variants were found in 12 patients (11.9%) with multiple diagnoses.

3 ecially for pediatric oncology patients, is the notion that patients and their families may not need or want palliative c

4 for identification, notification, and evaluation of exposed patients, and management of HCDs with regard to placement and

5 I sedations performed over a 5-year period using records of patients' biodata, MRI date, indication, findings and scan ti

6 Our data support the hypothesis, in a subpopulation of patients, DCs recruited at the diseased tissue produce high l

7 of 5.0 years (interquartile range, 3.5-6.0 years), 38 (15%) patients died and 106 (41%) either died or developed indicati

8 de YY and ghrelin in control subjects and in critically ill patients, during feeding and fasting, and to search for a cor

9 Work-related asthma patients exposed to protein allergens and isocyanates elicit

10 y sought to further explore the genetics in a larger set of patients following-up on the most promising genomic regions p

11 Younger patients had a higher likelihood of complete clinical success

12 Fifty-five percent of patients had grade 3 or 4 neurologic toxicities that complete

13 edian number of previous lines of therapy was two (2-5), 38 patients had high-risk cytogenetics, 17 were unresponsive to

14 Nonsentinel-node metastases, identified in 11.5% of the patients in the dissection group, were a strong, independent

15 From 2006 to 2012 the use of PC in ESLD patients increased substantially; socioeconomic, geographical

16 A perceived barrier, especially for pediatric oncology patients, is the notion that patients and their families may

17 Among 336 randomized patients (mean age, 68 years; 16% women), 333 completed the t

18 In these patients, median age was 58 years (IQR 51-62), median number

19 ted from patients with BOS (n = 10), stable lung transplant patients (n = 18), and healthy aged-matched controls (n = 10)

20 Patients presented with early-onset sensorineural deafness an

21 We generated iPSC-derived cardiomyocytes from patients presenting in vivo with extremely low or high change

22 care providers who assess patients' smoking status, educate patients regarding ocular risks of smoking, and discuss with

23 Glaucoma patients reported varied degrees of concern regarding items a

24 rompted primary care providers to perform HCV screening for patients seen in primary care clinic (1) born between 1945 an

25 atients regarding ocular risks of smoking, and discuss with patients smoking cessation options.

26 easures include proportion of eye care providers who assess patients' smoking status, educate patients regarding ocular r

27 Compared with 176 patients undergoing ViV, 72 patients undergoing ViR had lower left ventricular ejection f

28 Compared with 176 patients undergoing ViV, 72 patients undergoing ViR had lower

29 Patients were randomized to the liberal (hemoglobin threshold

30 In patients who reached the symptom threshold after inulin intak

31 Five eligible studies including 4360 patients with acute ICH were pooled in meta-analysis.

32 stablish the effect of MABp1 with a new primary endpoint in patients with advanced colorectal cancer.

33 n multivariate analysis, patients with irregular Z line and patients with BE of >/= 1 cm did not differ significantly in

34 imal, and small distal airway brushings were collected from patients with BOS (n = 10), stable lung transplant patients (

35 iomarkers and development of treatment solutions to benefit patients with breast cancer at high risk of recurrence.

36 Antifungal treatment is indicated in almost all patients with chronic cavitary pulmonary infections, chronic

37 In conclusion, we demonstrate a relevant number of patients with FDG-PET false-negative MM and a strong associat

38 y molecules are increased in inflamed intestinal tissues of patients with IBD.

39 The overall response rate for patients with IMT (treated at 100, 165, and 280 mg/m(2)/dose)

40 On multivariate analysis, patients with irregular Z line and patients with BE of >/= 1

41 zes during posturing and progresses during interruptions in patients with macula-on RD.

42 17 patients with MS and 11 healthy controls (HCs) underwent 3 ex

43 ndomyocardial biopsies and blood samples were obtained from patients with newly diagnosed cardiomyopathy and clinical sus

44 e Examination [MMSE] </=25) using data from nine cohorts of patients with Parkinson's disease from North America and Euro

45 ml (P=0.03), above the 90th percentile for the 5-mg dose in patients with preserved renal function.

46 Novel therapies are needed for patients with relapsed or refractory multiple myeloma (MM).

47 Patients with repetitive ventricular tachycardia/ventricular

48 st adequate dosing of antibiotics to improve the outcome of patients with sepsis.

49 Patients with severe extracranial injuries (AIS >/= 3), death

50 s at target and major adverse cardiovascular outcomes among patients with T1DM.

51 sensitivity of HTS permitted identification of 19.9% of SR patients without MRD at any detectable level who had excellen